Repligen Corp. (RGEN)
114.20
+0.44
(+0.39%)
USD |
NASDAQ |
Mar 13, 16:00
115.45
+1.25
(+1.09%)
Pre-Market: 08:18
Repligen Market Cap : 6.433B for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Masimo Corp. | 9.161B |
| Orthofix Medical, Inc. | 469.69M |
| InfuSystem Holdings, Inc. | 188.20M |
| Tandem Diabetes Care, Inc. | 1.475B |
| Plus Therapeutics, Inc. | 34.36M |
Market Cap Related Metrics
| PE Ratio | 132.10 |
| PS Ratio | 8.750 |
| Price to Book Value | 3.054 |
| Price to Free Cash Flow | 70.45 |
| Price | 114.20 |
| Earnings Yield | 0.76% |
| Operating PE Ratio | 126.90 |
| Normalized PE Ratio | 139.95 |